A Synthetic Bivalent Ligand of CXCR4 Inhibits HIV Infection

Biochemical and Biophysical Research Communications - United States
doi 10.1016/j.bbrc.2013.05.038
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Biological Effects of Bivalent-Type CXCR4 Ligands With Rigid Linkers

2013English

Targeting Chemokine Receptor CXCR4 for Treatment of HIV-1 Infection, Tumor Progression, and Metastasis

Current Topics in Medicinal Chemistry
MedicineDrug Discovery
2014English

Plectin Regulates the Signaling and Trafficking of the HIV-1 Co-Receptor CXCR4 and Plays a Role in HIV-1 Infection

Experimental Cell Research
Cell Biology
2008English

Chemokine Receptor CXCR4 Oligomerizes Independent of Ligand Binding

Seibutsu Butsuri
2003English

IFN-λ3 Inhibits HIV Infection of Macrophages Through the JAK-STAT Pathway

PLoS ONE
Multidisciplinary
2012English

Ibrutinib Inhibits SDF1/CXCR4 Mediated Migration in AML

Oncotarget
Oncology
2014English

A Small-Molecule Antagonist of CXCR4 Inhibits Intracranial Growth of Primary Brain Tumors

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2003English

RNAi Targeting CXCR4 Inhibits Proliferation and Invasion of Esophageal Carcinoma Cells

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2013English

Bryostatin Modulates Latent HIV-1 Infection via PKC and AMPK Signaling but Inhibits Acute Infection in a Receptor Independent Manner

PLoS ONE
Multidisciplinary
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy